Nuhey News

We talk about the MARKET

Global Artificial Pancreas Devices Systems Market Overview and Analysis of Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed and more

An artificial pancreas device system (APDS) is a medical device that automates the delivery of insulin to people with diabetes who require insulin therapy. It is a combination of a continuous glucose monitor (CGM) and an insulin pump that are connected to a computer algorithm that determines the amount of insulin needed. The algorithm is designed to maintain a healthy glucose level by automatically delivering the correct amount of insulin based on the CGM data.

The usage of an APDS is beneficial for people with Type 1 diabetes, who must monitor their blood glucose levels throughout the day and adjust their insulin dosage accordingly. The device helps to reduce the burden of managing diabetes by automating this process, allowing for more efficient glucose control.

The global Artificial Pancreas Devices Systems market was valued at US$ 89 million in 2022 and is anticipated to reach US$ 199.8 million by 2029, witnessing a CAGR of 12.1% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

A detailed market research report on Global Artificial Pancreas Devices Systems Market available at: https://www.themarketreports.com/report/global-artificial-pancreas-devices-systems-market-research-report

This report aims to provide a comprehensive presentation of the global market for Artificial Pancreas Devices Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Pancreas Devices Systems.

The key global companies of Artificial Pancreas Devices Systems include Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.

Ask for more details or sample of this report at: https://www.themarketreports.com/report/ask-your-query/1411349

Release by:

Shirish Gupta

Marketing Manager

The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479

Email: sales@themarketreports.com